255 related articles for article (PubMed ID: 22197626)
41. An overview of recent advances in pathogenesis and diagnosis of preeclampsia.
Savaj S; Vaziri N
Iran J Kidney Dis; 2012 Sep; 6(5):334-8. PubMed ID: 22976257
[TBL] [Abstract][Full Text] [Related]
42. OS089. Elevated levels of the heme scavenger alpha-1-microglobulin in maternal plasma at the end of first trimester in patients who subsequently develop preeclampsia.
Anderson UD; Hansson SR; Åkerström B; Olsson M
Pregnancy Hypertens; 2012 Jul; 2(3):226-7. PubMed ID: 26105302
[TBL] [Abstract][Full Text] [Related]
43. A1M Ameliorates Preeclampsia-Like Symptoms in Placenta and Kidney Induced by Cell-Free Fetal Hemoglobin in Rabbit.
Nääv Å; Erlandsson L; Axelsson J; Larsson I; Johansson M; Wester-Rosenlöf L; Mörgelin M; Casslén V; Gram M; Åkerström B; Hansson SR
PLoS One; 2015; 10(5):e0125499. PubMed ID: 25955715
[TBL] [Abstract][Full Text] [Related]
44. Statistical regression model of standard and new laboratory markers and its usefulness in prediction of preeclampsia.
Delić R; Štefanović M; Krivec Š; Weber V
J Matern Fetal Neonatal Med; 2014 Mar; 27(4):388-92. PubMed ID: 23795957
[TBL] [Abstract][Full Text] [Related]
45. Use of first or second trimester serum markers, or both, to predict preeclampsia.
Lambert-Messerlian G; Eklund EE; Chien EK; Rosene-Montella K; Neveux LM; Haddow HR; Palomaki GE
Pregnancy Hypertens; 2014 Oct; 4(4):271-8. PubMed ID: 26104816
[TBL] [Abstract][Full Text] [Related]
46. PP006. Gene expression profiling of first trimester placentas from pregnancies at high risk of developing preeclampsia.
Anderson UD; Thilaganathan B; Gram M; Åkerström B; Hansson SR
Pregnancy Hypertens; 2013 Apr; 3(2):69. PubMed ID: 26105862
[TBL] [Abstract][Full Text] [Related]
47. Long-term renal and cardiovascular risk after preeclampsia: towards screening and prevention.
Paauw ND; Luijken K; Franx A; Verhaar MC; Lely AT
Clin Sci (Lond); 2016 Feb; 130(4):239-46. PubMed ID: 26769659
[TBL] [Abstract][Full Text] [Related]
48. Candidate biochemical markers for screening of pre-eclampsia in early pregnancy.
Forest JC; Charland M; Massé J; Bujold E; Rousseau F; Lafond J; Giguère Y
Clin Chem Lab Med; 2012 Jun; 50(6):973-84. PubMed ID: 22706239
[TBL] [Abstract][Full Text] [Related]
49. Combining biochemical and ultrasonographic markers in predicting preeclampsia: a systematic review.
Giguère Y; Charland M; Bujold E; Bernard N; Grenier S; Rousseau F; Lafond J; Légaré F; Forest JC
Clin Chem; 2010 Mar; 56(3):361-75. PubMed ID: 20044446
[TBL] [Abstract][Full Text] [Related]
50. Longitudinal changes in plasma hemopexin and alpha-1-microglobulin concentrations in women with and without clinical risk factors for pre-eclampsia.
Murtoniemi K; Kalapotharakos G; Vahlberg T; Räikkonen K; Kajantie E; Hämäläinen E; Åkerström B; Villa PM; Hansson SR; Laivuori H
PLoS One; 2019; 14(12):e0226520. PubMed ID: 31841544
[TBL] [Abstract][Full Text] [Related]
51. Angiogenic proteins as aid in the diagnosis and prediction of preeclampsia.
Cerdeira AS; Karumanchi SA
Scand J Clin Lab Invest Suppl; 2010; 242():73-8. PubMed ID: 20515282
[TBL] [Abstract][Full Text] [Related]
52. Committee Opinion Summary No. 638: First-Trimester Risk Assessment for Early-Onset Preeclampsia.
Obstet Gynecol; 2015 Sep; 126(3):689. PubMed ID: 26287782
[TBL] [Abstract][Full Text] [Related]
53. FIRST TRIMESTER SCREENING FOR PREECLAMPSIA - A SYSTEMATIC REVIEW.
Mosimann B; Amylidi-Mohr SK; Surbek D; Raio L
Hypertens Pregnancy; 2020 Feb; 39(1):1-11. PubMed ID: 31670986
[No Abstract] [Full Text] [Related]
54. Preeclampsia biomarkers: An assessment of maternal cardiometabolic health.
Eastabrook G; Aksoy T; Bedell S; Penava D; de Vrijer B
Pregnancy Hypertens; 2018 Jul; 13():204-213. PubMed ID: 30177053
[TBL] [Abstract][Full Text] [Related]
55. Dynamic proteome in enigmatic preeclampsia: an account of molecular mechanisms and biomarker discovery.
Mary S; Patil GV; Kulkarni AV; Kulkarni MJ; Joshi SR; Mehendale SS; Giri AP
Proteomics Clin Appl; 2012 Jan; 6(1-2):79-90. PubMed ID: 22447695
[TBL] [Abstract][Full Text] [Related]
56. Shrunken pore syndrome, preeclampsia, and markers of NO metabolism in pregnant women during the first trimester.
Jarquin Campos A; Risch L; Baumann M; Purde MT; Neuber S; Renz H; Mosimann B; Raio L; Mohaupt M; Surbek D; Risch M
Scand J Clin Lab Invest; 2019; 79(1-2):91-98. PubMed ID: 30785340
[TBL] [Abstract][Full Text] [Related]
57. Prediction of preeclampsia - a workshop report.
Than NG; Romero R; Hillermann R; Cozzi V; Nie G; Huppertz B
Placenta; 2008 Mar; 29 Suppl A(Suppl A):S83-5. PubMed ID: 18061661
[TBL] [Abstract][Full Text] [Related]
58. Maternal Serum sEndoglin and Cell-Free Fetal DNA as Probable Markers of Preeclampsia: A Study in Single Center, Egypt.
Nabiel Y; Mosbah A
Immunol Invest; 2019 Aug; 48(6):608-617. PubMed ID: 30794004
[No Abstract] [Full Text] [Related]
59. [PRE-ECLAMPSIA: A NEW TEST FOR AN OLD DISEASE].
Svirsky R; Feldman N; Levinsohn-Tavor O; Galoyan N; Maymon R
Harefuah; 2018 May; 157(5):314-317. PubMed ID: 29804337
[TBL] [Abstract][Full Text] [Related]
60. Maternal-fetal interactions, predictive markers for preeclampsia, and programming.
Huppertz B
J Reprod Immunol; 2015 Apr; 108():26-32. PubMed ID: 25534924
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
